在基于VSV的系统中选择的SARS-CoV-2主蛋白酶 (Mpro) 抑制剂耐药突变体的综合研究
Francesco Costacurta1, Andrea Dodaro2, David Bante1
1Institute of Virology, Medical University of Innsbruck, Innsbruck, 6020, Tyrol, Austria.
bioRxiv : the preprint server for biology
|October 9, 2023
概括
研究人员发现了对第一种SARS-CoV-2蛋白酶抑制剂 (PI) - - 尼马特里尔维尔产生抗性的突变. 这项工作有助于理解耐药机制,并开发下一代PI来对抗不断演变的变种.
科学领域:
- 病毒学 病毒学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 尼尔马特里尔维尔是治疗SARS-CoV-2的关键蛋白酶抑制剂 (PI).
- 新出现的SARS-CoV-2变种可能会对当前的抗病毒疗法产生耐药性.
- 了解耐药机制对于正在进行的治疗策略至关重要.
研究的目的:
- 识别和描述赋予耐尼马特里尔病毒耐药性的突变.
- 调查已识别的耐药性突变的临床相关性.
- 为未来SARS-CoV-2蛋白酶抑制剂的开发提供信息.
主要方法:
- 通过一种仿真囊泡性口腔炎病毒 (VSV-Mpro) 随着尼尔马特里尔维尔度的增加.
- 使用武汉-1和Omicron SARS-CoV-2主蛋白酶 (Mpro) 变体进行突变的选择.
- 使用基于细胞和生化分析对抗性的表型表征.
- 在基分子建模以阐明阻力机制.
主要成果:
- 选择了大量的耐尼马特里尔维尔抗药性突变.
- 在GISAID数据库中经常观察到一些选定的突变,这表明临床相关性.
- 耐药性表型的特征是针对nirmatrelvir和ensitrelvir.
- 通过in silico建模确定了抗性的假定分子机制.
结论:
- 该研究确定了对nirmatrelvir.vir产生抗性的关键突变.
- 这些发现凸显了SARS-CoV-2可能对当前的PI产生抗药性的潜力.
- 结果为开发下一代Mpro抑制剂提供了洞察力,并为临床治疗决策提供了信息.
相关概念视频
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...